NN GROUP NV (NN.AS) 32.78 +0.08 (+0.24%)
32.78 +0.08 (+0.24%)
NL0010773842 - Common Stock
Fundamental Rating
We assign a fundamental rating of 3 out of 10 to NN. NN was compared to 19 industry peers in the Insurance industry. NN scores bad on very profitability, while its financial health is fine. Not spectacular, but in line with the averages. NN has a expensive valuation and it also scores bad on growth
Profitability
Profitability Rating
NN has a Return On Assets of 0.20%. This is below the industry average of 0.99%. 100% of the industry peers outperform NN.
NN has a Return On Equity of 2.40%. This is below the industry average of 15.70%. 100% of the industry peers outperform NN.
NN has a Profit Margin of 3.76%. This is below the industry average of 5.83%. 94% of the industry peers outperform NN.
The Piotroski-F score of NN is 3.00. This is a low score and indicates issues in the health and profitability of NN.
VS Industry
ROA (0.2%) VS Industry: 0% outperformed.
0.20
6.84
ROE (2.4%) VS Industry: 0% outperformed.
2.40
29.47
Profit Margin (3.76%) VS Industry: 6% outperformed.
2.42
27.91
Valuation
Valuation Rating
The Forward Price/Earnings Ratio of 6.06 indicates a rather cheap valuation of NN.
With a price book ratio of 0.52, NN is valued rather cheaply.
When comparing the price book ratio of NN to the average industry price book ratio of 1.08, NN is valued rather cheaply. NN is also cheaper than 94% of the companies listed in the same industry.
With a Price/Earnings Ratio of 22.76, NN is valued on the expensive side.
With a Price/Earning Ratio of 22.76, NN is valued a higher than the industry average, which is at 9.44. 94% of the companies listed in the same industry are cheaper than NN!
Compared to an average industry Enterprise Value to EBITDA ratio of 5.56, NN is valued more expensive than its industry peers. 90% of the companies listed in the same industry are valued cheaper.
VS Industry
Price/Earnings (22.76) VS Industry: 6% outperformed.
24.15
3.32
Price/Book (0.52) VS Industry: 94% outperformed.
3.99
0.42
Enterprise Value/ EBITDA (17.38) VS Industry: 10% outperformed.
67.66
3.07
Growth
Growth Rating
The EPS growth is accelerating: in the next 5 years the growth will be better than in the last years.
The Revenue growth is accelerating: in the next 5 years the growth will be better than in the last years.
NN is expected to show a decrease in Earnings Per Share. In the coming 5 years, the EPS will decrease by -1.13% yearly.
Measured over the past 5 years, NN shows a decrease in Revenue. The Revenue has been decreasing by -9.42% on average per year.
Based on estimates for the next 5 years, NN will show a decrease in Revenue. The Revenue will decrease by -0.15% on average per year.
NN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -86.15%.
NN shows a very negative growth in Earnings Per Share. Measured over the last 5 years, the EPS has been decreasing by -25.33% yearly.
NN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -51.77%.
| Past | Future | ||||||
|---|---|---|---|---|---|---|---|
| 5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |
| EPS | -25.33% | -36.96% | -86.15% | -24.48% | -10.48% | -5.77% | -1.13% |
| Revenue | -9.42% | -22.27% | -51.77% | 5.81% | 3.7% | 5.13% | -0.15% |
Health
Health Rating
NN is one of the better placed companies in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 0.93. NN has a better rating than 87% of its industry peers.
The Quick Ratio of NN is much better than the industry average of 0.93. NN has a better rating than 87% of its industry peers.
A Current Ratio of 1.92 indicates that NN should not have too much problems paying its short term obligations.
NN has a Quick Ratio of 1.92. This is a normal value and indicates that NN is financially healthy and should not expect problems in meeting its short term obligations.
NN has one of the worst Debt to Equity ratios in its industry. 89% of its industry peers require less debt for financing their operations.
Based on the Altman-Z score of 0.14, we must say that NN is in the distress zone and has some risk of bankruptcy.
When comparing the Altman-Z score of NN to the average industry Altman-Z score of 0.34, NN is less financially healthy than its industry peers. 100% of its industry peers have a better Altman-Z score.
NN has a quite weak Piotroski-F score of 3.00. This indicates issues in the health and profitability of NN.
VS Industry
Debt/Equity (0.87) VS Industry: 11% outperformed.
1.55
0.13
Quick Ratio (1.92) VS Industry: 87% outperformed.
0.14
89.12
Current Ratio (1.92) VS Industry: 87% outperformed.
0.14
89.12
Altman-Z (0.14) VS Industry: 0% outperformed.
0.14
1.21
Dividend
Dividend Rating
NN has a Yearly Dividend Yield of 7.50%, which is a nice return.
Compared to an average industry Dividend Yield of 5.89, NN pays a better dividend. On top of this NN pays more dividend than 82% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.60, NN pays a better dividend.
The dividend of NN is nicely growing with an annual growth rate of 8.91%!
The Dividend Rate of NN has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
125.53% of the earnings are spent on dividend by NN. This is not a sustainable payout ratio.
VS Industry
Dividend Yield (7.5%) VS Industry: 82% outperformed.
3.45
11.98
NN GROUP NV32.78
AMS:NN (3/29/2023, 9:53:02 AM)+0.08 (+0.24%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap9.32B
Analysts76
Price Target49.61 (51.34%)
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.5% |
Dividend Growth(5Y)8.91%
DP125.53%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
PT rev (1m)-0.17%
PT rev (3m)-1.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.68%
EPS NY rev (1m)-8.52%
EPS NY rev (3m)-8.52%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)10.95%
Revenue NY rev (3m)10.95%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.76 | ||
| Fwd PE | 6.06 | ||
| P/S | 0.82 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.52 | ||
| P/tB | 0.58 | ||
| EV/EBITDA | 17.38 |
EPS(TTM)1.44
EY4.39%
EPS(NY)5.41
Fwd EY16.51%
FCF(TTM)-28.93
FCFYN/A
OCF(TTM)-28.79
OCFYN/A
SpS39.93
BVpS62.53
TBVpS56.81
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.2% | ||
| ROE | 2.4% | ||
| ROIC | 0.34% | ||
| ROICexc | 0.35% | ||
| ROICexgc | 0.44% | ||
| OM | 7.85% | ||
| PM | 3.76% | ||
| GM | N/A |
ROICexgc(3y)1%
ROICexcg growth 3Y-25.56%
ROICexcg growth 5Y-19.23%
ROICexc(3y)0.78%
ROICexc growth 3Y-25.23%
ROICexc growth 5Y-19.07%
OM growth 3Y-7.28%
OM growth 5Y-11.06%
PM growth 3Y-21.83%
PM growth 5Y-19.39%
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.05
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.87 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 14.85 | ||
| Cap/Depr | 26.03% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.92 | ||
| Quick Ratio | 1.92 | ||
| Altman-Z | 0.14 |
F-Score3
WACC6.82%
ROIC/WACC0.06
Cap/Depr(3y)29.95%
Cap/Depr(5y)41.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
Growth
EPS 1Y-86.15%
EPS 3Y-36.96%
EPS 5Y-25.33%
EPS growth Q2Q-127.68%
EPS Next Y-24.48%
EPS Next 2Y-10.48%
EPS Next 3Y-5.77%
EPS Next 5Y-1.13%
Revenue growth 1Y-51.77%
Revenue growth 3Y-22.27%
Revenue growth 5Y-9.42%
Revenue growth Q2Q-25.82%
Revenue Next Year5.81%
Revenue Next 2Y3.7%
Revenue Next 3Y5.13%
Revenue Next 5Y-0.15%
EBIT growth 1Y-64.81%
EBIT growth 3Y-27.93%
EBIT growth 5Y-19.44%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-211.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-215.42%
OCF growth 3YN/A
OCF growth 5YN/A
Fundamental Stock Screener Links
Fundamental Stock Screener
Find stocks with similar Fundamental rating on the EuroNext
Best Fundamental Competitors Stock Screener
Find the competitors with the best fundamentals on the EuroNext
Best Valuation Competitors Stock Screener
Find the competitors with the best valuation on the EuroNext
Best Dividend Competitors Stock Screener
Find the competitors with the best dividend on the EuroNext